Gland Pharma financials at a glance

+ Portfolio

The revenue of Gland Pharma is reported as 55.23764 billion Rupees in the fiscal year 2024. The earnings were 51.6 Rupees per share in 2024, which was 32.14 lower than 2022. And about 6.33088 billion Rupees are reported as free cash flow in the financials of Gland Pharma 2024. No dividends were paid to the shareholders of the Gland Pharma stock NSEI:GLAND in the financial year 2024.

Rp36.25B

Revenue

Rp49.97

Earnings Per Share

48.70%

Gross Margin %

Rp1.43B

Free Cash Flow

Revenue

36,246.01

Earnings Per Share

49.97

Gross Margin %

48.70

Free Cash Flow

1,430.39

Financials

Year	Year	TTM	2023	2022	2021
Rev.	Revenue	N/A	Rp36.25B	Rp44.01B	Rp34.63B
GM %	Gross Margin %	53.96%	48.70%	48.89%	53.52%
OM	Operating Margin	19.99%	24.40%	31.81%	34.75%
EPS	Earnings Per Share	Rp42.42	Rp49.97	Rp73.64	Rp62.99
Div.	Dividends	N/A	Rp0.00	Rp0.00	Rp0.00
PR %	Payout Ratio %	0	0.00%	0.00%	0.00%
Sha.	Shares	N/AM	164.7M	164.3M	163.59M
OCF	Operating Cash Flow	N/A	Rp3.64B	Rp7.91B	Rp6.05B
FCF	Free Cash Flow	N/A	Rp1.43B	Rp2.80B	Rp3.76B
FCFS	Free Cash Flow Per Share	Rp5.05	Rp8.56	Rp16.37	Rp23.80

Gland Pharma financials at a glance

Financials

Discover